Jianpeng Yu
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
PCAT1 Supports Partial AR-V7 Function and Promotes Enzalutamide Resistance in Prostate Cancer.
Journal: International journal of general medicine
Published: April 16, 2026
Comparative safety profiles of enzalutamide, olaparib, and lutetium Lu-177 vipivotide tetraxetan in patients with prostate cancer: a real-world disproportionality analysis of the FAERS database.
Journal: World journal of urology
Published: February 20, 2026
Molecular mechanisms and classification of castration-resistant prostate cancer: Insights into androgen receptor, cancer stem cells, and neuroendocrine features.
Journal: Current urology
Published: March 11, 2025
Monoacylglycerol lipase blockades the senescence-associated secretory phenotype by interfering with NF-κB activation and promotes docetaxel efficacy in prostate cancer.
Journal: Oncogene
Published: December 14, 2023
CYTOR drives prostate cancer progression via facilitating AR-V7 generation and its oncogenic signalling.
Journal: Clinical and translational medicine
Published: December 27, 2022
Identification of LAT/ZAP70 characterized immune subtypes of prostate cancer.
Journal: World journal of urology
Published: August 14, 2022
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer.
Journal: Cell death & disease
Published: August 14, 2022
Circular RNAs in Prostate Cancer: Is it Time to Further Explore Liquid Biopsies?
Journal: Mini reviews in medicinal chemistry
Published: July 18, 2022
Last Updated: 09/26/2026